THE MAIN CAUSE OF HIV/AIDS INFECTION DISEASE

Authors

  • Aannisah Fauzaania
  • Hamzah Hasyim
  • Atik Wulandari
  • Deasy Sumarni
  • Deasy Sumarni
  • Aidil Fitrianto
  • Bayu Anggriani
  • ani meliyani
  • Ahmad Taher

DOI:

https://doi.org/10.35730/jk.v12i0.625

Abstract

 

Background: The emergence of Human Immunodeficiency Virus (HIV) has delivered large fitness demanding situations to youngsters and young people round the sector manifesting as biological, psychological, and social problems. This then have become a worldwide project which isn't always simplest depending on the fitness quarter, however additionally the complete authorities quarter in widespread due to the effect of HIV sickness which has the capacity to assault all groups.

Purpose: behavior a literature overview on HIV/AIDS. This literature overview will describe the primary reasons of HIV primarily based totally on a few dependable references.

Method: the use of a literature overview with the database used is Pubmed, a literature seek method with the keywords "HIV", "AIDs", and "HIV/AIDs".Result: Our meta-evaluation discovered that the pooled occurrence estimate of AUD amongst PLWHA changed into determined to be 29.80% (95% CI; 24.10–35.76). Conclusion: Results discovered that the primary motive of HIV contamination among men changed into the injection of narcotics, and withinside the girls it changed into sexual sex with an inflamed individual.

 

References

T. Girum, A. Wasie, and A. Worku, ‘Trend of HIV/AIDS for the last 26 years and predicting achievement of the 90-90-90 HIV prevention targets by 2020 in Ethiopia: A time series analysis’, BMC Infect. Dis., vol. 18, no. 1, pp. 1–10, 2018, doi: 10.1186/s12879-018-3214-6.

R. W. Eisinger and A. S. Fauci, ‘Ending the HIV/AIDS Pandemic’, Emerg. Microbes Infect., vol. 7, no. 1, pp. 413–416, 2018, doi: 10.1038/s41426-018-0062-9.

J. L. Dieleman et al., ‘Spending on health and HIV/AIDS: domestic health spending and development assistance in 188 countries, 1995–2015’, Lancet, vol. 391, no. 10132, pp. 1799–1829, 2018, doi: 10.1016/S0140-6736(18)30698-6.

P. Mandsager, A. Marier, S. Cohen, M. Fanning, H. Hauck, and L. W. Cheever, ‘Reducing HIV-related health disparities in the Health Resources and Services Administration’s Ryan White HIV/AIDS program’, Am. J. Public Health, vol. 108, pp. S246–S250, 2018, doi: 10.2105/AJPH.2018.304689.

B. Duko, M. Ayalew, and G. Ayano, ‘The prevalence of alcohol use disorders among people living with HIV/AIDS: A systematic review and meta-analysis’, Subst. Abus. Treat. Prev. Policy, vol. 14, no. 1, pp. 1–9, 2019, doi: 10.1186/s13011-019-0240-3.

R. Cabrera-Rodríguez et al., ‘The Interplay of HIV and Autophagy in Early Infection’, Front. Microbiol., vol. 12, no. April, pp. 1–27, 2021, doi: 10.3389/fmicb.2021.661446.

R. H. Remien, M. J. Stirratt, N. Nguyen, R. N. Robbins, A. N. Pala, and C. A. Mellins, ‘Mental health and HIV/AIDS: The need for an integrated response’, Aids, vol. 33, no. 9, pp. 1411–1420, 2019, doi: 10.1097/QAD.0000000000002227.

S. Sari L. Reisner, ‘Global Health Burden and Needs of Transgender Populations: A Review’, Physiol. Behav., vol. 176, no. 1, pp. 100–106, 2016, doi: 10.1016/S0140-6736(16)00684-X.Global.

M. Mehraeen, M. Heydari, K. B. Lankarani, H. Joulaei, and M. Faghih, ‘Investigating the contributing factors to HIV/AIDS infection from the perspective of HIV-infected patients’, BMC Psychol., vol. 9, no. 1, pp. 1–8, 2021, doi: 10.1186/s40359-021-00513-w.

S. M. Anderson et al., ‘Vitamin D status impacts genital mucosal immunity and markers of HIV-1 susceptibility in women’, Nutrients, vol. 12, no. 10, pp. 1–15, 2020, doi: 10.3390/nu12103176.

Z. Belayneh, B. Mekuriaw, T. Mehare, S. Shumy, and M. Tsehay, ‘Magnitude and predictors of common mental disorder among people with HIV/AIDS in Ethiopia: A systematic review and meta-analysis’, BMC Public Health, vol. 20, no. 1, pp. 1–11, 2020, doi: 10.1186/s12889-020-08800-8.

M. M. Rahman, A. S. Lemin, and C. A. Pangarah, ‘Factors affecting discrimination toward people with HIV/AIDS in Sarawak, Malaysia’, HIV AIDS Rev., vol. 9, no. 1, pp. 49–55, 2020, doi: 10.5114/hivar.2019.85916.

A. Olatayo Adeoti, M. U. Dada, and J. O. Fadare, ‘Prevalence of Depression and Anxiety Disorders in People Living with HIV/AIDS in a Tertiary Hospital in South Western Nigeria’, Med. Reports Case Stud., vol. 03, no. 01, pp. 3–7, 2018, doi: 10.4172/2572-5130.1000150.

Z. Behboodi-Moghadam, A. Nikbakht-Nasrabadi, A. Ebadi, S. Esmaelzadeh–Saeieh, and M. Mohraz, ‘Fertility desire in Iranian women with HIV: A qualitative study’, Iran. J. Public Health, vol. 44, no. 8, pp. 1126–1134, 2015.

P. P. Dobrakowski and S. Skalski, ‘Personality changes in HIV-infected patients who have been receiving highly active antiretroviral therapy’, HIV AIDS Rev., vol. 18, no. 3, pp. 165–175, 2019, doi: 10.5114/hivar.2019.88445.

C. Sistiarani, B. Hariyadi, M. Munasib, and S. M. Sari, ‘Stigma and gender dimension based on rural and urban communities in preventing HIV and AIDS in childbearing age couples in Banyumas Regency’, HIV AIDS Rev., vol. 9, no. 1, pp. 61–66, 2020, doi: 10.5114/hivar.2020.93178.

Y. Ransome, K. A. Thurber, M. Swen, N. D. Crawford, D. German, and L. T. Dean, ‘Social capital and HIV/AIDS in the United States: Knowledge, gaps, and future directions’, SSM - Popul. Heal., vol. 5, no. May, pp. 73–85, 2018, doi: 10.1016/j.ssmph.2018.05.007.

S. Antwerpes et al., ‘nutrients Coffee Intake and Neurocognitive Performance’, pp. 1–13, 2020.

Q. Xiao, D. Guo, and S. Chen, ‘Application of CRISPR/Cas9-based gene editing in HIV-1/AIDS therapy’, Front. Cell. Infect. Microbiol., vol. 9, no. MAR, pp. 1–15, 2019, doi: 10.3389/fcimb.2019.00069.

E. A. Silveira, M. O. Falco, A. S. e. A. de C. Santos, M. Noll, and C. de Oliveira, ‘Nutritional intervention reduces dyslipidemia, fasting glucose and blood pressure in people living with hiv/aids in antiretroviral therapy: A randomized clinical trial comparing two nutritional interventions’, Nutrients, vol. 12, no. 10, pp. 1–18, 2020, doi: 10.3390/nu12102970.

U. M. Parikh, K. McCormick, G. Van Zyl, and J. W. Mellors, ‘Future technologies for monitoring HIV drug resistance and cure’, Curr. Opin. HIV AIDS, vol. 12, no. 2, pp. 182–189, 2017, doi: 10.1097/COH.0000000000000344.

S. N. Desai and A. L. Landay, ‘HIV and aging: Role of the microbiome’, Curr. Opin. HIV AIDS, vol. 13, no. 1, pp. 22–27, 2018, doi: 10.1097/COH.0000000000000433.

N. Phanuphak and R. M. Gulick, ‘HIV treatment and prevention 2019: Current standards of care’, Curr. Opin. HIV AIDS, vol. 15, no. 1, pp. 4–12, 2020, doi: 10.1097/COH.0000000000000588.

S. Mehta, C. Schairer, and S. Little, ‘Ethical Issues in HIV Phylogenetics’, Physiol. Behav., vol. 176, no. 1, pp. 139–148, 2019, doi: 10.1097/COH.0000000000000538.Ethical.

D. Sauter and F. Kirchhoff, ‘HIV replication: A game of hide and sense’, Curr. Opin. HIV AIDS, vol. 11, no. 2, pp. 173–181, 2016, doi: 10.1097/COH.0000000000000233.

V. Miller, J. Nwokike, and A. Stergachis, ‘Pharmacovigilance and global HIV/AIDS’, Curr. Opin. HIV AIDS, vol. 7, no. 4, pp. 299–304, 2012, doi: 10.1097/COH.0b013e328354d8e7.

R. Lorenzo-Redondo, E. A. Ozer, C. J. Achenbach, R. T. D’Aquila, and J. F. Hultquist, ‘Molecular epidemiology in the HIV and SARS-CoV-2 pandemics’, Curr. Opin. HIV AIDS, vol. 16, no. 1, pp. 11–24, 2021, doi: 10.1097/COH.0000000000000660.

M. Pancera, A. Changela, and P. D. Kwong, ‘How HIV-1 entry mechanism and broadly neutralizing antibodies guide structure-based vaccine design’, vol. 12, no. 3, pp. 229–240, 2018, doi: 10.1097/COH.0000000000000360.How.

N. Bbosa, P. Kaleebu, and D. Ssemwanga, ‘HIV subtype diversity worldwide’, Curr. Opin. HIV AIDS, vol. 14, no. 3, pp. 153–160, 2019, doi: 10.1097/COH.0000000000000534.

S. J. Taleski, K. Ahmed, and A. Whiteside, ‘The relationship between economic evaluations and HIV and AIDS treatment policies’, Curr. Opin. HIV AIDS, vol. 5, no. 3, pp. 204–209, 2010, doi: 10.1097/COH.0b013e3283384b58.

Downloads

Published

2024-09-02

Issue

Vol. 12 (2021): Supplementary 2

Section

Artikel

Most read articles by the same author(s)

<< < 1 2 3